Literature DB >> 8704543

Potentially lethal bacterial infection associated with varicella zoster virus.

A J Pollard1, A Isaacs, E G Hermione Lyall, N Curtis, K Lee, S Walters, M Levin.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8704543      PMCID: PMC2351699          DOI: 10.1136/bmj.313.7052.283

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  33 in total

1.  Post-varicella streptococcal pyomyositis.

Authors:  S A Raphael; S C Longenecker; B J Wolfson; M C Fisher
Journal:  Pediatr Infect Dis J       Date:  1989-03       Impact factor: 2.129

2.  Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins.

Authors:  G J Kotwal; B Moss
Journal:  Nature       Date:  1988-09-08       Impact factor: 49.962

3.  Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

Authors:  L A Cone; D R Woodard; P M Schlievert; G S Tomory
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

4.  Varicella and life-threatening streptococcal infection.

Authors:  C M Fischbacher; S T Green
Journal:  Scand J Infect Dis       Date:  1987

5.  Subgaleal abscess: an unusual presentation.

Authors:  J F Wiley; J M Sugarman; L M Bell
Journal:  Ann Emerg Med       Date:  1989-07       Impact factor: 5.721

Review 6.  Superantigens and their potential role in human disease.

Authors:  B L Kotzin; D Y Leung; J Kappler; P Marrack
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

7.  Bacteremia with group A streptococci in childhood.

Authors:  C D Christie; P L Havens; E D Shapiro
Journal:  Am J Dis Child       Date:  1988-05

8.  Streptococcus associated toxic shock.

Authors:  C Torres-Martínez; D Mehta; A Butt; M Levin
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

9.  Group A beta-hemolytic streptococci as a cause of bacteremia in children.

Authors:  V K Wong; H T Wright
Journal:  Am J Dis Child       Date:  1988-08

10.  Group A streptococcal bacteremia in a mid-south children's hospital.

Authors:  R J Leggiadro; M C Bugnitz; B A Peck; G S Luedtke; M H Kim; E L Kaplan; P M Schlievert
Journal:  South Med J       Date:  1993-06       Impact factor: 0.954

View more
  9 in total

1.  Necrotising fasciitis of the submandibular region.

Authors:  Ea Nyako; No Nartey
Journal:  Ghana Med J       Date:  2006-06

2.  Kingella kingae endocarditis following chickenpox in infancy.

Authors:  D J Waghorn; C H Cheetham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

3.  Bacterial superinfection in chickenpox....but it can occur at any age.

Authors:  A J Barnes; A S Johnson; M P Shelly; C I Orton
Journal:  BMJ       Date:  1996-11-02

4.  Bacterial superinfection in chickenpox. Children are probably more susceptible...

Authors:  B A Bovill; B A Bannister
Journal:  BMJ       Date:  1996-11-02

5.  Non-steroidal anti-inflammatory drugs may predispose to invasive group A streptococcal infections.

Authors:  N Curtis
Journal:  Arch Dis Child       Date:  1996-12       Impact factor: 3.791

6.  Rare Varicella zoster virus infection in an ALT free flap.

Authors:  Jun Ho Lee; Hwan Jun Choi
Journal:  Int Wound J       Date:  2015-02-17       Impact factor: 3.315

7.  First reported cluster of overwhelming group A streptococcal septicaemia and associated chickenpox infection in the UK.

Authors:  Andrew Gustaf Nyman; Helen Wolfenden; Prem Roy; Jill Morris
Journal:  BMJ Case Rep       Date:  2009-02-02

8.  Varicella infection in a neonate with subsequent staphylococcal scalded skin syndrome and fatal shock.

Authors:  Shakal Narayan Singh; Mohammad Tahazzul; Anita Singh; Surabhi Chandra
Journal:  BMJ Case Rep       Date:  2012-08-01

9.  Incidence of herpes zoster and associated events including stroke--a population-based cohort study.

Authors:  Karin Sundström; Caroline E Weibull; Karin Söderberg-Löfdal; Tomas Bergström; Pär Sparén; Lisen Arnheim-Dahlström
Journal:  BMC Infect Dis       Date:  2015-10-31       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.